N

Minerva Neurosciences
D

NERV

1.99000
USD
-0.06
(-2.93%)
مغلق
حجم التداول
7
الربح لكل سهم
-3
العائد الربحي
-
P/E
2
حجم السوق
13,916,878
أصول ذات صلة
A
ANVS
-0.19000
(-6.74%)
2.63000 USD
C
CRVS
0.01500
(0.35%)
4.27000 USD
C
CYCC
4.840
(58.45%)
13.120 USD
M
MGTX
-0.03000
(-0.35%)
8.61000 USD
NTRA
NTRA
-4.587
(-3.20%)
138.830 USD
X
XNCR
-0.12000
(-1.32%)
8.96000 USD
المزيد
الأخبار المقالات

العنوان: Minerva Neurosciences

القطاع: Healthcare
الصناعة: Biotechnology
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.